Xarelto is one of a new class of blood thinners introduced to the market in the last several years. It was developed by drug giant Bayer and marketed by Janssen Pharmaceutica, and has been available in the United States since July 1, 2011, when the U.S. Food and Drug Administration approved its use for patients undergoing hip and knee replacement surgery to prevent deep vein thrombosis.
A few months later it was approved for the prevention of stroke in people with non-valvular atrial fibrillation. Though the drug proved popular and was quickly viewed as an improvement over Warfarin, its safety was quickly called into question when patients taking the drug started experiencing severe internal bleeding, in some cases resulting in death.
The problem with Xarelto lies in the fact that there is no way to reverse its impact. Where the medication that was traditionally prescribed to prevent blood clots could quickly be reversed through the administration of a shot of Vitamin K, when a patient has Xarelto in their blood system the only antidote is time: physicians who need to operate or stop a bleeding event in a Xarelto patient are forced to wait until the medication is flushed out of the patient’s system. In a surgical emergency or a case of uncontrollable bleeding, the patients are at high risk for death.
If someone you love died or suffered injury as a result of having taken Xarelto, we can help. Contact us at 1-866-222-9990 to set up a free consultation to discuss your rights.
Xarelto Carries Additional Risks
In addition to being associated with a high risk for uncontrollable bleeding, over the last few years it has become apparent that Xarelto carries additional unacceptable risks.
Some patients have experienced decreased hemoglobin counts, complications from surgery, including infections and leakage associated with their knee and hip replacements, bleeding in the brain and higher risk of hematoma.
They have also experienced swelling of the lower limbs and difficulty in breathing. Though these risks are greater for those who are over the age of 65 or who are in poor health, the negative side effects and risks of Xarelto have been seen in a wide range of patients.
As a result, the FDA has required that several changes be made to Xarelto’s warning labels over the last few years. Unfortunately, many of these warnings came too late for those who had already taken the medication and been harmed by it.
Many of those who took Xarelto and experienced harmful side effects have died, and others have suffered tremendous physical pain and illness as a result of this medication.
For the families who have lost loved ones and those who have suffered, filing a Xarelto lawsuit against Bayer offers the possibility of receiving compensation for medical expenses, lost wages and earnings capacity, and more.
These lawsuits hold the company responsible for having failed to provide complete information about the drug’s safety and risks.
Latest Xarelto News
- Appeal Filed After Judge Excludes Evidence In Xarelto Case
- Philadelphia Jury Hears of Dangers of Xarelto
- FDA Delays Approval of Xarelto Antidote
- Philadelphia Jury Awards Xarelto Victim $28 Million
- Xarelto Users File Wrongful Death Suit against Janssen R&D
- New Jersey Man Sues Xarelto Manufacturers over Gastrointestinal Bleeding
- Xarelto Manufacturers Sued over Alleged Complications
- Louisiana Woman Sues Xarelto Manufacturers over Life-threatening Bleeding
- California Man Files Xarelto Lawsuit
- TX Woman Files $4.5M Lawsuit against Pharmaceutical Companies over Alleged Xarelto-related Injuries